Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $299.5800 (6.51%) ($281.7900 - $300.2000) on Tue. Apr. 29, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.86% (three month average) | RSI | 57 | Latest Price | $299.5800(6.51%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.8% a day on average for past five trading days. | Weekly Trend | REGN declines -0.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XBI(38%) XLV(38%) QQQ(32%) SPY(30%) VT(28%) | Factors Impacting REGN price | REGN will decline at least -1.43% in a week (0% probabilities). TLT(-7%) TIP(-3%) SHY(-3%) IGOV(-3%) UUP(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.43% (StdDev 2.86%) | Hourly BBV | 0 () | Intraday Trend | 5.9% | | | |
|
5 Day Moving Average | $292.35(2.47%) | 10 Day Moving Average | $295.9(1.24%) | 20 Day Moving Average | $295.43(1.4%) | To recent high | -10.1% | To recent low | 6.5% | Market Cap | $31.764b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |